Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production. | Front Immunol | 2024 | 38515751 | PubTator, text mining | PubMed |
| Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer. | Int J Mol Sci | 2024 | 38473906 | PubTator, text mining | PubMed |
| The role of Tetraspanins in digestive system tumor development: update and emerging evidence. | Front Cell Dev Biol | 2024 | 38389703 | PubTator, text mining | PubMed |
| "Triple-Punch" Strategy Exosome-Mimetic Nanovesicles for Triple Negative Breast Cancer Therapy. | ACS Nano | 2024 | 38335265 | PubTator, text mining | PubMed |
| Epidemiology of Bartonella henselae infection in pet and stray cats in Croatia with risk factors analysis. | Parasit Vectors | 2024 | 38303085 | PubTator, text mining | PubMed |
| Roles of exosomes in immunotherapy for solid cancers. | Cell Death Dis | 2024 | 38302430 | PubTator, text mining | PubMed |
| Exosomal microRNAs in regulation of tumor cells resistance to apoptosis. | Biochem Biophys Rep | 2024 | 38298209 | PubTator, text mining | PubMed |
| A state-of-the-art review of the recent advances in exosome isolation and detection methods in viral infection. | Virol J | 2024 | 38291452 | PubTator, text mining | PubMed |
| Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application. | J Nanobiotechnology | 2024 | 38281957 | PubTator, text mining | PubMed |
| Microscopic clusters feature the composition of biochemical tetraspanin-assemblies and constitute building-blocks of tetraspanin enriched domains. | Sci Rep | 2024 | 38267610 | PubTator, text mining | PubMed |
| The role and applications of extracellular vesicles in osteoporosis. | Bone Res | 2024 | 38263267 | PubTator, text mining | PubMed |
| Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer. | PeerJ | 2024 | 38259671 | PubTator, text mining | PubMed |
| Exploring Peripheral Blood-Derived Extracellular Vesicles as Biomarkers: Implications for Chronic Chagas Disease with Viral Infection or Transplantation. | Microorganisms | 2024 | 38257943 | PubTator, text mining | PubMed |
| CuAAC-Based Synthesis, Copper-Catalyzed Aldehyde-Forming Hydrolytic Fission and Antiproliferative Evaluation of Novel Ferrocenoylamino-Substituted Triazole-Tethered Quinine-Chalcone Hybrids. | Molecules | 2024 | 38257289 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication. | Int J Mol Sci | 2024 | 38256278 | PubTator, text mining | PubMed |
| Spatial Transcriptomic Profiling of Tetraspanins in Stage 4 Colon Cancer from Primary Tumor and Liver Metastasis. | Life (Basel) | 2024 | 38255741 | PubTator, text mining | PubMed |
| Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women. | Genes (Basel) | 2024 | 38254997 | PubTator, text mining | PubMed |
| Immune Cell-Derived Exosomes in Inflammatory Disease and Inflammatory Tumor Microenvironment: A Review. | J Inflamm Res | 2024 | 38250144 | PubTator, text mining | PubMed |
| Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care. | Cells | 2024 | 38247870 | PubTator, text mining | PubMed |
| Characterization of Listeria monocytogenes Strains Isolated in Palermo (Sicily and Italy) during the Years 2018-2020 from Severe Cases of Listeriosis. | Antibiotics (Basel) | 2024 | 38247616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=7